Beijing Strong Biotechnologies, Inc. (300406.SZ) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 20Aug 25Aug 28Sep 2Sep 7Sep 10Sep 15Sep 18

Key dataSep 18, 2026

OpenCNY 11.27

From 52W high−24.43%

Volume3.25M

Market capCNY 6.75B

P/E (TTM)35.5x

P/S (TTM)4.9x

Div yield9.21%

Key dataSep 18, 2026

Open

CNY 11.27

From 52W high

−24.43%

Volume

3.25M

Market cap

CNY 6.75B

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

19.6x

P/E (TTM)

35.5x

RSI (14)

45.6

MomentumView details →

1D Return

−1.62%

YTD Return

−12.78%

ValuationView details →

P/E (Fwd)

—

P/E (TTM)

35.5x

EV/EBITDA

19.6x

EV/Sales

4.4x

P/S (TTM)

4.9x

P/B (TTM)

2.0x

ProfitabilityView details →

Gross Margin

79.63%

Net Margin

15.49%

EBITDA Margin

22.37%

ROE (TTM)

5.45%

ROA (TTM)

4.09%

Asset Turnover

0.27x

GrowthView details →

Revenue YoY

−13.52%

EPS YoY

−57.62%

FCF YoY

−10.22%

Revenue CAGR 3Y

−3.55%

EPS CAGR 3Y

−21.83%

EBITDA YoY

—

MomentumView details →

1D Return

−1.62%

YTD Return

−12.78%

1Y Return

−15.56%

RSI (14)

45.6

vs 50D SMA

−1.69%

vs 200D SMA

−8.10%

Capital & dividendView details →

Debt/Equity

0.00x

Current Ratio

12.18x

Quick Ratio

11.20x

Div Yield

9.21%

Div Rate

CNY 1.05

Div Growth 1Y

+350.00%

EarningsView details →

EPS (Actual)

CNY 0.18

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Financials snapshotView financials →

Revenue (TTM)

1.37B

Net Income (TTM)

212.22M

Op. CF (TTM)

589.67M

Latest newsMore news →

Beijing Strong Biotechnologies plans to subscribe to 26,212 yuan of newly added registered capital in its associate Zhongke Natai at 1 yuan per yuan of registered capital as part of Zhongke Natai's equity restructuring, and to waive its repurchase right and right of first refusal under the 2021 shareholders' agreement, raising its stake from 5.1387% to 6.3520%.4d ago

Similar companies

银禧科技300221.SZ 长海股份300196.SZ 山东墨龙002490.SZ 鑫磊股份301317.SZ 中远通301516.SZ 永新股份002014.SZ Find similar companies →

Latest newsMore news →

Beijing Strong Biotechnologies plans to subscribe to 26,212 yuan of newly added registered capital in its associate Zhongke Natai at 1 yuan per yuan of registered capital as part of Zhongke Natai's equity restructuring, and to waive its repurchase right and right of first refusal under the 2021 shareholders' agreement, raising its stake from 5.1387% to 6.3520%.4d ago